JIJarunee Intrapiromkul

Jarunee Intrapiromkul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jarunee Intrapiromkul has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Mark Mamlouk

    Department of Radiology The Permanente Medical Group, Kaiser Permanente Medical Center Santa Clara California USA

    2 shared publications
  • Pattana Wangaryattawanich

    Department of Radiology University of Washington School of Medicine Seattle Washington USA

    2 shared publications
  • Raghu Ramakrishnaiah

    Department of Radiology University of Arkansas of Medical Sciences, Arkansas Children's Hospital Little Rock Arkansas USA

    2 shared publications
  • Rajan Patel

    Edward B. Singleton Department of Radiology Texas Children’s Hospital and Baylor College of Medicine Houston Texas USA

    2 shared publications
  • Stephen Kralik

    Edward B. Singleton Department of Radiology Texas Children’s Hospital and Baylor College of Medicine Houston Texas USA

    2 shared publications
  • Zoltan Patay

    St. Jude Children's Research Hospital Memphis Tennessee USA

    2 shared publications

Latest Publications

  • Imaging of pediatric calvarial and skull base tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White Paper

    by Jarunee Intrapiromkul, Pattana Wangaryattawanich, Zoltan Patay, Thierry A.G.M. Huisman, Jason N. Wright, Jeremy Y. Jones, Raghu Ramakrishnaiah, Rajan Patel, Adam E. Goldman‐Yassen, Stephen Kralik, et al.

    A standardized imaging protocol for pediatric oncology patients is essential for accurate and efficient imaging, while simultaneously promoting collaborative understanding of pathologies and radiologic assessment of treatment response. The objective of this article is to provide standardized pediatric imaging guidelines and parameters for evaluation of tumors of the pediatric orbit, calvarium, skull base, and temporal bone. This article was drafted based on current scientific literature as well as consensus opinions of imaging experts in collaboration with the Children's Oncology Group Diagnostic Imaging Committee, Society of Pediatric Radiology Oncology Committee, and American Society of Pediatric Neuroradiology.


  • Open Access

    IMAGING OF PEDIATRIC CALVARIAL AND SKULL BASE TUMORS: A COG DIAGNOSTIC IMAGING COMMITTEE/SPR ONCOLOGY COMMITTEE/ASPNR WHITE PAPER

    by Jarunee Intrapiromkul, Pattana Wangaryattawanich, Zoltan Patay, Thierry Huisman, Jason Wright N, Jeremy Jones, Raghu Ramakrishnaiah, Rajan Patel, Adam Goldman-Yassen, Stephen Kralik, et al.

    INTRODUCTIONThe frequency of pediatric head and neck neoplasms ranges from approximately 2-15% of all pediatric cancers1. Skull base and calvarial neoplasms, including temporal bone and orbital masses are a subset of head and neck neoplasms occupying a number of neoplastic processes and categorically encompass several imaging patterns: singular dominant mass lesions with or without metastatic disease (e.g., rhabdomyosarcoma (RMS), chordoma), singular or multifocal metastatic disease (e.g., neuroblastoma), and multifocal disease due to systemic malignancy (e.g., leukemia, lymphoma, histiocytosis, etc.).While pathologies certainly vary between pediatric and adult patients, there remains significant overlap. As such, imaging protocols for skull base and calvarial neoplasms are similar in their general construct. However, optimized pediatric-specific protocols remain a must, as a retrofitted adult head and neck protocol is often ill equipped to offer quality, efficient and safe imaging (e.g., limiting radiation exposure) of the size-variable infant and pediatric patient. Moreover, sedation or general anesthesia is often required in the pediatric population in order to minimize motion artifact. Thus, optimization of imaging acquisition time is a very important technical consideration because it may decrease the necessity and duration of sedation/anesthesia and their potential risks in this vulnerable population. Standardized protocols for anatomic sub sites of the head and neck offer significant benefit in individual patient follow up on a local scale, and, on a broader scale, allow for collaborative understanding of imaging pathologies and innovative or benchmarked standardized treatment response assessment across institutions.In an effort to standardize protocols, this article offers minimum, pediatric specific anatomy-based initial and follow up imaging guidelines for pediatric malignancies of the orbits, calvarium, skull base and temporal bone. This manuscript was funded in part by the National Clinical Trials Network Operations Center Grant U10CA180886. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

  • Characterization of Restenosis following Carotid Endarterectomy Using Contrast-Enhanced Vessel Wall MR Imaging

    by W. Yang, B.A. Wasserman, H. Yang, L. Liu, G. Orman, J. Intrapiromkul, H.H. Trout, Y. Qiao

    BACKGROUND AND PURPOSE: Restenosis is an important determinant of the long-term efficacy of carotid endarterectomy. Our aim was to assess the role of high-resolution vessel wall MR imaging for characterizing restenosis after carotid endarterectomy. MATERIALS AND METHODS: Patients who underwent vessel wall MR imaging after carotid endarterectomy were included in this study. Restenotic lesions were classified as myointimal hyperplasia or recurrent atherosclerotic plaques based on MR imaging features of lesion compositions. Imaging characteristics of myointimal hyperplasia were compared with those of normal post-carotid endarterectomy and recurrent plaque groups. Recurrent plaques were matched with primary plaques by categories of stenosis, and differences in plaque features were compared between the 2 groups. RESULTS: Twenty-two recurrent lesions from 18 patients (14 unilateral and 4 bilateral) were classified as myointimal hyperplasia or recurrent plaque. Myointimal hyperplasia showed no difference in enhancement compared with normal post-carotid endarterectomy vessels (5 unilateral) but showed stronger enhancement than recurrent plaques (80.10% [SD, 42.42%] versus 56.74% [SD, 46.54%], P = .042). A multivariate logistic regression model of plaque-feature detection in recurrent plaques compared with primary plaques adjusted for maximum wall thickness revealed that recurrent plaques were longer (OR, 4.27; 95% CI, 1.32–13.85; P = .015) and more likely to involve a flow divider and side walls (OR, 6.96; 95% CI, 1.37–35.28; P = .019). Recurrent plaques had a higher prevalence of intraplaque hemorrhage (61.5% versus 30.8%, P = .048) by a χ2 test, but compositional differences were not significant in the multivariate model. CONCLUSIONS: Vessel wall MR imaging can distinguish recurrent plaques from myointimal hyperplasia and reveal features that may differ between primary and recurrent plaques, highlighting its value for evaluating patients with carotid restenosis.